Show results for
Refine by
Industries served
- Medical / Health Care
- Agriculture
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Environmental
- Food and Beverage
- Water and Wastewater
- Health and Safety
- Manufacturing, Other
- Energy
- Construction & Construction Materials
- Mining
- Automobile & Ground Transport
- Defense
- Domestic
- Aerospace & Air Transport
- Forestry & Wood
- Commercial
- Real Estate
- Waste and Recycling
- Oil, Gas & Refineries
- Air and Climate
- Government
Antibiotic Resistance Suppliers Serving Tonga
56 companies found
based inChatswood, AUSTRALIA
Next Science® pioneers innovative, proprietary technologies to address one of the leading causes of antimicrobial resistance, bacterial biofilms. With proven, experienced management and scientific leadership, Next Science and its partners deliver ...
Biofilms pose a far-reaching threat to humans, animals and the environment. The continuing rise in antimicrobial resistance necessitates effective diagnosis and management of biofilm-associated infections. Collectively, infections contribute to ...
based inSouth Melbourne, AUSTRALIA
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate income from partnerships including with other vaccine and infectious ...
BDM-I: Addressing market need for next-generation antimicrobials. Infectious diseases often dominate the media headlines, including rising antibiotic resistance and fear of “super bugs”. One serious ...
based inAntwerp, BELGIUM
At Innovad we combine people’s long time experiences in the field of animal feed and water additives with an innovative approach and dedication to animal well-being and a healthy environment. At the same time we secure cost effectiveness for the ...
based inSeraing, BELGIUM
Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins to improve microbial fermentation. Our team of scientists works in different academic laboratories and our R&D programs involve partners from ...
Syngulon develops antibiotic-free technologies for use in so-called “micro-refineries”, microbial cells that have been engineered to produce industrially relevant compounds. These technologies incorporate bacteriocins into the ...
based inSALUGGIA, ITALY
We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years we have been dealing with diagnostics to help physicians and patients make better decisions in the ...
The VERIGENE System enables clinicians to rapidly identify the pathogens responsible for some of the most complex, costly, and deadly infectious ...
based inIvry sur Seine, FRANCE
Germitec is specialized in the High-Level Disinfection of ultrasound probes. It has developed the Antigermix® system which replaces chemistry with photons and thus constitutes a technological breakthrough. With its technology based on UV-C ...
based inColumbia City, INDIANA (USA)
Nanovis is a technology-driven company committed to discovering unmet clinical needs, developing innovative and enabling solutions, and validating new technologies for clinical and market acceptance. Founded in 2008 by Brian Emerick and licensed ...
based inLangenfeld, GERMANY
ARTES Biotechnology is a globally working, well established and reliable technology provider for recombinant protein production. We develop microbial cell lines and processes for vaccines, biopharmaceuticals, biosimilars and enzymes and offer ...
ARTES uses one of the most important industrial expression systems, the methylotrophic yeast Hansenula polymorpha (syn. Pichia angusta). For our platform technology, we have all relevant IP rights as well as unpatent know-how. Our expertise is on ...
based inAbingdon, UNITED KINGDOM
Thermally Stable Needle Free Solid Dose Vaccines. Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies. These diseases affect millions of ...
Antimicrobial resistance (AMR) can arise when the organisms that cause an infection evolve ways to survive and render treatments ineffective, facilitating the infection’s spread. Global human consumption of ...
based inKirkland, WASHINGTON (USA)
MICRO, the Mold Inspection Consulting and Remediation Organization, is the industry’s leading provider of exceptional Mold Training. Through our professionally designed training programs thousands of people have become Certified Mold Inspectors ...
based inMalmö, SWEDEN
The Perstorp Group is a world leader in several sectors of the specialty chemicals market for a wide variety of industries and applications. Our products are added to a wide range of products used every day at home, work or leisure. Building on more ...
based inBootle, UNITED KINGDOM
Mast Group Ltd. is an independent world class manufacturer and supplier of diagnostic products for clinical, industrial and veterinary testing. The parent company, Mast Group Ltd, has corporate headquarters in Bootle near Liverpool, UK. Mast Group ...
based inSan Diego, CALIFORNIA (USA)
Quidel Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved ...
Acute conjunctivitis (adenoviral conjunctivitis or “pink eye”) is an inflammation that can be caused by infections from bacteria or viruses. Pink eye can also be caused by allergy, eye injury, or reaction to ...
based inWhite City, OREGON (USA)
Biomed Diagnostics is the resulting collaboration of two physicians who found themselves vulnerable without the necessary equipment during a mercy mission in Central America. Without the necessary refrigeration, practical supplies and laboratory ...
based inGembloux, BELGIUM
Based in Belgium and established in 1996, Coris BioConcept is a middle-sized company (SME) specialized in developing, manufacturing and marketing rapid diagnostic kits for the detection of human respiratory, gastro-enteric and blood-borne pathogens ...
Reagents kit for preparation of blood cultures before performing a RESIST test. Compatible for all the targets of our RESIST kits at the exception of OXA-163 and OXA-23 (not yet ...
based inVeghel, NETHERLANDS
We improve the health and well-being of plants, animals and consumers. Our innovative strength creates sustainable growth and financial returns for farmers and businesses. Intracare develops, produces and supplies proven and effective veterinary ...
based inBruxelles, BELGIUM
Belgiophar, a young and dynamic Belgian start-up which develops and distributes its own supplements, it is located in Belgium, in the Brussels-Capital Region, near the Erasme hospital, Allée de la Recherche, where many leading pharmaceutical and ...
based inLondon, UNITED KINGDOM
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in orphan diseases, ...
Staphylococcus aureus are gram-positive bacteria and the leading cause of skin and soft tissue infections, but can cause serious infections such as pneumonia, bacteraemia, and bone infections. Vancomycin is the most frequently prescribed treatment ...
based inCambridge, MASSACHUSETTS (USA)
The human body is an ecosystem. Trillions of microbes call us home. They form the human microbiome, which performs critical functions that preserve our health including modulating our immune system and providing colonization resistance against ...
VE707 is a preclinical discovery program for the prevention of infection and colonization recurrence of several multi-drug resistant organisms (MDROs) including carbapenem-resistant Enterobacteriaceae (CRE), extended-spectrum beta lactamase ...
based inNorwich, UNITED KINGDOM
We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...
Proprietary nanoparticles deliver an oligonucleotide inside the bacterial pathogen. The oligonucleotide acts as a Transcription Factor Decoy (TFD): it contains the binding site of a transcription factor that controls a large set of genes required ...
